Search research articles
Contact Us
Filters
Showing results (11-20 of 165) with videos related to
Page
of 17
Sort By:
Expert Opinion on Therapeutic Patents
|
December 15, 2016
Therapeutic applications of the versatile fatty acid mimetic WY14643
Julius Pollinger, Daniel Merk
Journal of Medicinal Chemistry
|
July 7, 2022
Medicinal Chemistry and Chemical Biology of Nurr1 Modulators: An Emerging Strategy in Neurodegeneration
Sabine Willems, Daniel Merk
Future Medicinal Chemistry
|
November 22, 2011
Innovations in the treatment of cystic fibrosis: outriders for the treatment of diseases with other genetic defects?
Manfred Schubert-Zsilavecz, Daniel Merk
Pharmazie in Unserer Zeit
|
July 31, 2012
[Non-agonist inhibitors of Cdk5-dependent phosphorylation of PPAR as insulin sensitizers in the future?]
Daniel Merk, Manfred Schubert-Zsilavecz
Future Medicinal Chemistry
|
March 8, 2012
New hope or drawbacks: will chronic kidney disease be treatable with small molecules in the near future?
Daniel Merk, Manfred Schubert-Zsilavecz
Expert Opinion on Drug Discovery
|
April 12, 2013
Repairing mutated proteins--development of small molecules targeting defects in the cystic fibrosis transmembrane conductance regulator
Daniel Merk, Manfred Schubert-Zsilavecz
Future Medicinal Chemistry
|
October 10, 2012
Novel strategies to control lipid metabolism: can the antisense drug mipomersen fulfill the unmet need?
Daniel Merk, Manfred Schubert-Zsilavecz
Future Medicinal Chemistry
|
March 31, 2012
Nuclear receptors as pharmaceutical targets: rise of FXR and rebirth of PPAR?
Daniel Merk, Manfred Schubert-Zsilavecz
Future Medicinal Chemistry
|
June 11, 2015
Natural compound renews hope for diabetes and obesity therapeutic target
Daniel Merk, Manfred Schubert-Zsilavecz
Journal of Medicinal Chemistry
|
May 21, 2021
The Medicinal Chemistry of Caffeine
Giuseppe Faudone, Silvia Arifi, Daniel Merk
Page
of 17
Search research articles
Search
Showing results (11-20 of 165) with videos related to
Sort By:
Page
of 17
Expert Opinion on Therapeutic Patents
|
December 15, 2016
Therapeutic applications of the versatile fatty acid mimetic WY14643
Julius Pollinger, Daniel Merk
Journal of Medicinal Chemistry
|
July 7, 2022
Medicinal Chemistry and Chemical Biology of Nurr1 Modulators: An Emerging Strategy in Neurodegeneration
Sabine Willems, Daniel Merk
Future Medicinal Chemistry
|
November 22, 2011
Innovations in the treatment of cystic fibrosis: outriders for the treatment of diseases with other genetic defects?
Manfred Schubert-Zsilavecz, Daniel Merk
Pharmazie in Unserer Zeit
|
July 31, 2012
[Non-agonist inhibitors of Cdk5-dependent phosphorylation of PPAR as insulin sensitizers in the future?]
Daniel Merk, Manfred Schubert-Zsilavecz
Future Medicinal Chemistry
|
March 8, 2012
New hope or drawbacks: will chronic kidney disease be treatable with small molecules in the near future?
Daniel Merk, Manfred Schubert-Zsilavecz
Expert Opinion on Drug Discovery
|
April 12, 2013
Repairing mutated proteins--development of small molecules targeting defects in the cystic fibrosis transmembrane conductance regulator
Daniel Merk, Manfred Schubert-Zsilavecz
Future Medicinal Chemistry
|
October 10, 2012
Novel strategies to control lipid metabolism: can the antisense drug mipomersen fulfill the unmet need?
Daniel Merk, Manfred Schubert-Zsilavecz
Future Medicinal Chemistry
|
March 31, 2012
Nuclear receptors as pharmaceutical targets: rise of FXR and rebirth of PPAR?
Daniel Merk, Manfred Schubert-Zsilavecz
Future Medicinal Chemistry
|
June 11, 2015
Natural compound renews hope for diabetes and obesity therapeutic target
Daniel Merk, Manfred Schubert-Zsilavecz
Journal of Medicinal Chemistry
|
May 21, 2021
The Medicinal Chemistry of Caffeine
Giuseppe Faudone, Silvia Arifi, Daniel Merk
Page
of 17